Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Valerie A. Gerriets, Jeffrey C. Rathmell(University of Chicago), Catherine Huck(Novartis (Switzerland)), Andrew N. Macintyre(Duke University), Lea Haeberli(Novartis (Switzerland)), Nancie J. MacIver(University of North Carolina at Chapel Hill), Martin Schneider(Novartis (Switzerland)), Kris C. Wood(Duke University), Jason W. Locasale(Duke University), Paul A. Smith(Incyte (United States)), Amanda Nichols(Duke University), Laurence A. Turka(Harvard University), Olga Ilkayeva(Duke University), Christopher B. Newgard(Duke Medical Center), Marta E. Slawinska(Novartis (Switzerland)), Peter Winter(Duke University), Mari L. Shinohara(Duke University), Laura P. Hale(Duke University), Xiaojing Liu(Duke University), Makoto Inoue(University of Illinois Urbana-Champaign), Bhavana Priyadharshini(Harvard University), Rigel J. Kishton
Cited by 717
Related Papers
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Potential of fecal microbiota for early‐stage detection of colorectal cancer
|Molecular Systems Biology|2014|1.4k
Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement
|Nature Biotechnology|2013|1.3k
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
|Nature Genetics|2011|1.1k